Here we have shown in a humanized TNFR1-ki mouse that inhibiting the effects of TNF signalling through TNFR1 using a human-specific TNFR1 antagonistic antibody has beneficial effects in EAE, a mouse model of MS. This evidence concerns the gene TNFRSF1A and myeloid sarcoma.